Neutrophil-to-Lymphocyte ratio as a prognostic marker of mortality and disease severity in septic Acute kidney injury Patients: A retrospective study. 2023

Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
Division of Nephrology and Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, China.

BACKGROUND Acute kidney injury (AKI) is a frequent complication of sepsis associated with increased mortality and morbidity. The neutrophil-to-lymphocyte ratio (NLR) has been shown as a risk factor for septic AKI. In this study, we aimed to further evaluate NLR's prediction value on the prognosis of septic AKI patients. METHODS Septic AKI patients at a tertiary university-affiliated medical center were retrospectively enrolled from August 2015 to August 2021. The primary outcomes were 30-day and 90-day mortality, and secondary outcomes were disease severity, length of stay, and rehospitalization in survivors. Kaplan-Meier curves, Cox proportional hazards, cubic spline and logistics regression analyses were performed for adverse outcomes basing on NLR. The predictive value of NLR on morality was also estimated by the area under the receiver operating characteristic curve (AUROC). RESULTS A total of 309 septic AKI patients were included with a mean age of 57.8 ± 18.1 years and 92 (29.8 %) being female. The 30-day mortality was 43.4 % and 90-day morality was 61.8 %. When divided by the median of NLR at hospital admission, patients in the high NLR group were associated with an increased 30-day/90-day mortality. After adjusting for multiple covariates, the predictive value of NLR remained significant for 30-day mortality (HR: 2.96, 95 % CI: 1.48-5.92, p = 0.002) and 90-day mortality (HR: 1.88, 95 % CI: 1.11-3.16, p = 0.018). NLR at admission had the highest AUROC (0.618) for 30-day mortality compared with other parameters such as white blood cell (0.573), neutrophil (0.579), lymphocyte (0.567), platelet (0.546), BUN (0.580), albumin (0.545), C-reactive protein (0.571) and procalcitonin (0.534). A similar predictive value on mortality was also observed for NLR measured at septic AKI diagnosis. For secondary outcomes, high NLR was associated with increased risk of transfer to ICU, mechanical ventilation, stage-3 AKI and renal replacement therapy, but not with length of hospital/ICU stay or long-term rehospitalization. CONCLUSIONS High NLR is independently associated with 30-day/90-day mortality and disease severity in septic AKI patients. NLR may serve as an economic and widely available biomarker of septic AKI prognosis.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
January 2020, Nefrologia,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
February 2017, The American journal of emergency medicine,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
December 2024, Renal failure,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
January 2018, Journal of thoracic disease,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
May 2019, International immunopharmacology,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
January 2023, International urology and nephrology,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
December 2020, Clinical nutrition ESPEN,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
January 2020, Medicina,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
September 2022, Biomolecules,
Wei Wei, and Xiaorong Huang, and Letian Yang, and Jian Li, and Caihong Liu, and Yajun Pu, and Wenhui Yu, and Bo Wang, and Liang Ma, and Ling Zhang, and Ping Fu, and Yuliang Zhao
February 2024, Kidney research and clinical practice,
Copied contents to your clipboard!